Skip to main content
September 1, 2026
Today, the House Energy & Commerce Committee’s Subcommittee on Communications and Technology passed the bipartisan GUARD Act introduced by Chairman John Moolenaar (R-MI) of the Select Committee on China, Congressman Jay Obernolte (R-CA), and Congresswoman Jennifer McClellan (D-VA). The legislation requires robots made by China and other foreign adversaries to be reviewed for national security threats and prohibits those found to be a threat from being imported into the United States.

August 31, 2026

Today, the House of Representatives passed bipartisan legislation that will target Chinese companies who abuse our nation’s trade laws. The Protecting American Industry and Labor from International Trade Crimes Act would create a new Department of Justice task force to enforce trade-related crimes committed by Chinese companies including but not limited to tariff and duty evasion, import and export restrictions, trade-based money laundering, smuggling, and other import and export-related crimes. The legislation is led by Select Committee on China (SCC) Chairman John Moolenaar and SCC members Congresswoman Ashley Hinson (R-IA), Congressman Raja Krishnamoorthi (D-IL), and others.


August 25, 2026

Chairman John Moolenaar of the House Select Committee on China made the following statement on fast fashion company Shein's plans for its initial public offering (IPO) on the Hong Kong Stock Exchange next month, after failing to go public in New York and London due to Shein's use of slave labor:

“For major U.S. banks to bankroll Shein’s IPO shows these institutions have no regard for human rights or the victims of forced labor who will be forced to pick cotton for Shein’s clothes. It is unconscionable for the American leaders of these institutions to claim they care about U.S. national security and then underwrite a company tied to the CCP and its forced labor and genocide. Enabling the human rights abuses of Shein and the CCP is a stain they will never be able to wash out unless they end their support for this IPO immediately.”


August 25, 2026

Chairman John Moolenaar (R-MI) of the House Select Committee on China (SCC), Ranking Member Ro Khanna (D-CA), SCC Member Congressman Dan Newhouse (R-WA), and Congressman Jake Auchincloss (D-MA), have reintroduced the CCP Fentanyl Sanctions Act. This legislation cracks down on China-based and CCP-backed entities engaged in drug trafficking by targeting the Chinese chemical manufacturers and online vendors profiting from poisoning Americans.


August 21, 2026

Chairman John Moolenaar of the Select Committee on China (R-MI) and Congressman Ben Cline (R-VA) have sent


August 21, 2026
Chairman John Moolenaar of the Select Committee on China (R-MI) and Congressman Ben Cline (R-VA) have sent a letter to Acting Commissioner Kyle Diamantas of the Food and Drug Administration (FDA) calling on the agency to stop the use of drug trial data from China for new clinical trial or drug applications unless the FDA has inspected the trial site in the past 12 months. The letter follows the tragic news of three deaths – including two children – that were covered up in drug trials in China.

August 18, 2026

Chairman John Moolenaar of the Select Committee on China made the following statement regarding the Pentagon’s order for


August 13, 2026

Today, the Select Committee on China and the House Education and Workforce Committee released a new investigation titled Compromised Independence: CCP Influence at Harvard University.


August 13, 2026
Today, the Select Committee on China and the House Education and Workforce Committee released a new investigation titled Compromised Independence: CCP Influence at Harvard University. The investigation reveals more details on Harvard University's relationship with Chinese Communist Party (CCP)-linked entities tied to China's military and human rights abuses.

August 10, 2026
Chairman John Moolenaar of the Select Committee on China recently sent a letter to Under Secretary Jeffrey Kessler at the Bureau of Industry and Security (BIS) asking the bureau to make it clear that the Foundry Due Diligence Rule remains in effect.